These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2045 related articles for article (PubMed ID: 9486650)

  • 21. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
    Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
    J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cell-mediated recognition of human trophoblast.
    Biassoni R; Bottino C; Millo R; Moretta L; Moretta A
    Semin Cancer Biol; 1999 Feb; 9(1):13-8. PubMed ID: 10092546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
    Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE
    J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.
    Carretero M; Cantoni C; Bellón T; Bottino C; Biassoni R; Rodríguez A; Pérez-Villar JJ; Moretta L; Moretta A; López-Botet M
    Eur J Immunol; 1997 Feb; 27(2):563-7. PubMed ID: 9045931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CD94/NKG2A--a kind of inhibitory receptor belonging to C-type lectin superfamily].
    Wang Y; Zhu LP; Zhang W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):653-5. PubMed ID: 12905700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.
    Sivori S; Vitale M; Bottino C; Marcenaro E; Sanseverino L; Parolini S; Moretta L; Moretta A
    Eur J Immunol; 1996 Oct; 26(10):2487-92. PubMed ID: 8898964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.
    Borrego F; Kabat J; Sanni TB; Coligan JE
    J Immunol; 2002 Dec; 169(11):6102-11. PubMed ID: 12444112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells.
    Nattermann J; Nischalke HD; Hofmeister V; Ahlenstiel G; Zimmermann H; Leifeld L; Weiss EH; Sauerbruch T; Spengler U
    Am J Pathol; 2005 Feb; 166(2):443-53. PubMed ID: 15681828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
    Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K
    J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.
    Zingoni A; Palmieri G; Morrone S; Carretero M; Lopez-Botel M; Piccoli M; Frati L; Santoni A
    Eur J Immunol; 2000 Feb; 30(2):644-51. PubMed ID: 10671222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.
    Lee N; Llano M; Carretero M; Ishitani A; Navarro F; López-Botet M; Geraghty DE
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5199-204. PubMed ID: 9560253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How do NK cells sense the expression of HLA-G class Ib molecules?
    López-Botet M; Navarro F; Llano M
    Semin Cancer Biol; 1999 Feb; 9(1):19-26. PubMed ID: 10092547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells.
    Vance RE; Tanamachi DM; Hanke T; Raulet DH
    Eur J Immunol; 1997 Dec; 27(12):3236-41. PubMed ID: 9464811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T cell receptor-mediated recognition of HLA-E.
    García P; Llano M; de Heredia AB; Willberg CB; Caparrós E; Aparicio P; Braud VM; López-Botet M
    Eur J Immunol; 2002 Apr; 32(4):936-44. PubMed ID: 11920559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.
    Navarro F; Llano M; Bellón T; Colonna M; Geraghty DE; López-Botet M
    Eur J Immunol; 1999 Jan; 29(1):277-83. PubMed ID: 9933109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics.
    Kaiser BK; Barahmand-Pour F; Paulsene W; Medley S; Geraghty DE; Strong RK
    J Immunol; 2005 Mar; 174(5):2878-84. PubMed ID: 15728498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
    Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
    J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
    J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
    Lin Chua H; Brahmi Z
    Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 103.